CALC
CalciMedica, Inc.$0.78+0.03 (+4.49%)Prev Close$0.74·MCap$9.3M·P/E—·Vol197.2K·Yield—
▲
Buys (12M)
17
$381.1K
▼
Sells (12M)
1
$3.6K
◆
Net Activity
Net Buyer
$377.4K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at CalciMedica, Inc. (CALC) has been dominated by buying, with 17 insider purchases totaling $381.1K and 1 insider sale totaling $3.6K. The most recent insider transaction was by Middleton Fred A (director, 10 percent owner: ), who purchased $200.0K worth of shares on Jun 29, 2026. CalciMedica, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $9.3M.
CALC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Middleton Fred A | director, 10 percent owner: | Buy | 248,972 | $0.80 | $200.0K1.6% OS | 1,063,272+31% |
| Sep 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,500 | $3.07 | $7.7K | 0 |
| Sep 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,400 | $2.68 | $9.1K | 0 |
| Sep 12, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.12 | $15.6K | 0 |
| Sep 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,343 | $3.15 | $7.4K | 0 |
| Aug 28, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 10,000 | $2.85 | $28.5K | 0 |
| Aug 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,508 | $2.79 | $9.8K | 0 |
| Aug 19, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy | 9,563 | $2.82 | $27.0K | 0 |
| Aug 19, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,000 | $2.74 | $8.2K | 0 |
| Aug 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,076 | $2.90 | $14.7K | 0 |
| Aug 14, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy | 5,976 | $2.74 | $16.4K | 0 |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy | 1,000 | $3.96 | $4.0K | 0 |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Sell | 1,000 | $3.65 | $3.6K | 0 |
| Jul 22, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 1,500 | $3.78 | $5.7K | 0 |
| Jul 21, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 1,000 | $3.40 | $3.4K | 0 |
| Jul 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 1,500 | $3.37 | $5.1K | 0 |
| Jul 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,000 | $2.88 | $5.8K | 0 |
| Jul 18, 2025 | WILSON ROBERT N | Director | Buy | 4,500 | $2.87 | $12.9K | 0 |
| Jul 14, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 2,500 | $2.47 | $6.2K | 0 |
| Jul 14, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 6,500 | $2.43 | $15.8K | 0 |
| Jul 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $1.60 | $8.0K | 0 |
| Jul 1, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy | 1,000 | $1.85 | $1.9K | 0 |
| Jun 26, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 4,500 | $1.44 | $6.5K | 0 |
| Jun 24, 2025 | Bardin Stephen | Chief Financial Officer | Buy | 2,000 | $1.50 | $3.0K | 0 |
| Jun 11, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $1.85 | $9.3K | 0 |
| Jun 5, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 10,100 | $1.74 | $17.5K | 0 |
| May 30, 2025 | Bardin Stephen | Chief Financial Officer | Buy | 1,000 | $1.69 | $1.7K | 0 |
| Dec 6, 2024 | MIDDLETON FRED A | Director | Buy | 4,800 | $2.65 | $12.7K | 0 |
| Nov 1, 2024 | MIDDLETON FRED A | Director | Buy | 107,744 | $3.75 | $404.0K0.7% OS | 0 |
| Nov 1, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 53,333 | $3.75 | $200.0K | 0 |
| Aug 27, 2024 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 1,000 | $4.19 | $4.2K | 0 |
| Aug 23, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.57 | $17.9K | 0 |
| Aug 23, 2024 | WILSON ROBERT N | Director | Buy | 54,000 | $3.72 | $200.8K | 0 |
| Aug 21, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $4.04 | $20.2K | 0 |
| Jun 28, 2024 | WILSON ROBERT N | Director | Buy | 51,278 | $3.52 | $180.5K | 0 |
| Jun 27, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.22 | $16.1K | 0 |
| Jun 27, 2024 | WILSON ROBERT N | Director | Buy | 8,443 | $3.23 | $27.3K | 0 |
| Apr 1, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 4,000 | $3.90 | $15.6K | 0 |
| Jan 23, 2024 | MIDDLETON FRED A | Director | Buy | 679,384 | $3.70 | $2.52M4.3% OS | 0 |
| Dec 11, 2023 | WILSON ROBERT N | Director | Buy | 506 | $3.30 | $1.7K | 0 |
| Nov 7, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 2,000 | $3.34 | $6.7K | 0 |
| Nov 6, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 2,440 | $3.12 | $7.6K | 0 |
| Nov 6, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,400 | $3.12 | $7.5K | 0 |
| Nov 3, 2023 | Hebbar Sudarshan | Chief Medical Officer | Buy | 36,000 | $2.74 | $98.6K | 0 |
| Nov 3, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 5,000 | $2.85 | $14.3K | 0 |
| Nov 3, 2023 | Roberts Eric W | Chief Business Officer | Buy | 24,009 | $2.79 | $66.9K | 0 |
| Aug 25, 2023 | Roberts Eric W | Chief Business Officer | Buy | 736 | $3.18 | $2.3K | 0 |
| Aug 21, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,464 | $3.26 | $8.0K | 0 |
| Jun 23, 2023 | Roberts Eric W | Chief Business Officer | Buy | 1,900 | $3.59 | $6.8K | 0 |
| Jun 20, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,500 | $4.27 | $10.7K | 0 |
Showing 1–50 of 93
1 / 2
CALC Insider Buying Activity
The following table shows recent insider purchases of CalciMedica, Inc. (CALC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Middleton Fred A | director, 10 percent owner: | Buy | 248,972 | $0.80 | $200.0K1.6% OS | 1,063,272+31% |
| Sep 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,500 | $3.07 | $7.7K | 0 |
| Sep 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,400 | $2.68 | $9.1K | 0 |
| Sep 12, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.12 | $15.6K | 0 |
| Sep 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,343 | $3.15 | $7.4K | 0 |
| Aug 28, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 10,000 | $2.85 | $28.5K | 0 |
| Aug 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,508 | $2.79 | $9.8K | 0 |
| Aug 19, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy | 9,563 | $2.82 | $27.0K | 0 |
| Aug 19, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 3,000 | $2.74 | $8.2K | 0 |
| Aug 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,076 | $2.90 | $14.7K | 0 |
| Aug 14, 2025 | Hebbar Sudarshan | Chief Medical Officer | Buy | 5,976 | $2.74 | $16.4K | 0 |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy | 1,000 | $3.96 | $4.0K | 0 |
| Jul 22, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 1,500 | $3.78 | $5.7K | 0 |
| Jul 21, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 1,000 | $3.40 | $3.4K | 0 |
| Jul 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 1,500 | $3.37 | $5.1K | 0 |
| Jul 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 2,000 | $2.88 | $5.8K | 0 |
| Jul 18, 2025 | WILSON ROBERT N | Director | Buy | 4,500 | $2.87 | $12.9K | 0 |
| Jul 14, 2025 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 2,500 | $2.47 | $6.2K | 0 |
| Jul 14, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 6,500 | $2.43 | $15.8K | 0 |
| Jul 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $1.60 | $8.0K | 0 |
| Jul 1, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Buy | 1,000 | $1.85 | $1.9K | 0 |
| Jun 26, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 4,500 | $1.44 | $6.5K | 0 |
| Jun 24, 2025 | Bardin Stephen | Chief Financial Officer | Buy | 2,000 | $1.50 | $3.0K | 0 |
| Jun 11, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $1.85 | $9.3K | 0 |
| Jun 5, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 10,100 | $1.74 | $17.5K | 0 |
| May 30, 2025 | Bardin Stephen | Chief Financial Officer | Buy | 1,000 | $1.69 | $1.7K | 0 |
| Dec 6, 2024 | MIDDLETON FRED A | Director | Buy | 4,800 | $2.65 | $12.7K | 0 |
| Nov 1, 2024 | MIDDLETON FRED A | Director | Buy | 107,744 | $3.75 | $404.0K0.7% OS | 0 |
| Nov 1, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 53,333 | $3.75 | $200.0K | 0 |
| Aug 27, 2024 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | Buy | 1,000 | $4.19 | $4.2K | 0 |
| Aug 23, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.57 | $17.9K | 0 |
| Aug 23, 2024 | WILSON ROBERT N | Director | Buy | 54,000 | $3.72 | $200.8K | 0 |
| Aug 21, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $4.04 | $20.2K | 0 |
| Jun 28, 2024 | WILSON ROBERT N | Director | Buy | 51,278 | $3.52 | $180.5K | 0 |
| Jun 27, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 5,000 | $3.22 | $16.1K | 0 |
| Jun 27, 2024 | WILSON ROBERT N | Director | Buy | 8,443 | $3.23 | $27.3K | 0 |
| Apr 1, 2024 | Roberts Eric W | CHIEF BUSINESS OFFICER | Buy | 4,000 | $3.90 | $15.6K | 0 |
| Jan 23, 2024 | MIDDLETON FRED A | Director | Buy | 679,384 | $3.70 | $2.52M4.3% OS | 0 |
| Dec 11, 2023 | WILSON ROBERT N | Director | Buy | 506 | $3.30 | $1.7K | 0 |
| Nov 7, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 2,000 | $3.34 | $6.7K | 0 |
| Nov 6, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 2,440 | $3.12 | $7.6K | 0 |
| Nov 6, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,400 | $3.12 | $7.5K | 0 |
| Nov 3, 2023 | Hebbar Sudarshan | Chief Medical Officer | Buy | 36,000 | $2.74 | $98.6K | 0 |
| Nov 3, 2023 | Leheny A. Rachel | Chief Executive Officer | Buy | 5,000 | $2.85 | $14.3K | 0 |
| Nov 3, 2023 | Roberts Eric W | Chief Business Officer | Buy | 24,009 | $2.79 | $66.9K | 0 |
| Aug 25, 2023 | Roberts Eric W | Chief Business Officer | Buy | 736 | $3.18 | $2.3K | 0 |
| Aug 21, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,464 | $3.26 | $8.0K | 0 |
| Jun 23, 2023 | Roberts Eric W | Chief Business Officer | Buy | 1,900 | $3.59 | $6.8K | 0 |
| Jun 20, 2023 | Roberts Eric W | Chief Business Officer | Buy | 2,500 | $4.27 | $10.7K | 0 |
CALC Insider Selling Activity
The following table shows recent insider sales of CalciMedica, Inc. (CALC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | Sell | 1,000 | $3.65 | $3.6K | 0 |
CALC Insiders
Similar Stocks to CALC
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B